Hereditary hyper-ACE-emia due to the Pro1199Leu mutation of somatic ACE as a potential pitfall in diagnosis: a first family outside Europe

Clin Chem Lab Med. 2006;44(9):1088-9. doi: 10.1515/CCLM.2006.200.

Abstract

Elevated plasma levels of angiotensin converting enzyme (ACE) are associated with granulomatous diseases. However, several families of autosomal dominant hyper-ACE-emia without disease association have already been reported. Recently, the ACE mutation c.3705C>T (Pro1199Leu) was identified as the genetic correlate in European cases of asymptomatic autosomal dominant hyper-ACE-emia. Here, we describe a first family outside Europe with asymptomatic autosomal-dominant hyper-ACE-emia due to the ACE Pro1199Leu mutation. Benign autosomal-dominant hyper-ACE-emia should be considered for differential diagnosis of elevated ACE levels worldwide.

MeSH terms

  • Cytosine / chemistry
  • Europe
  • Female
  • Genetic Predisposition to Disease*
  • Granuloma / genetics*
  • Granuloma / pathology
  • Humans
  • Leucine / genetics*
  • Male
  • Peptidyl-Dipeptidase A / blood
  • Peptidyl-Dipeptidase A / genetics*
  • Point Mutation*
  • Proline / genetics*
  • Thymine / chemistry

Substances

  • Cytosine
  • Proline
  • Peptidyl-Dipeptidase A
  • Leucine
  • Thymine